DK2912074T3 - Dermal injicerbar steril sammensætning - Google Patents

Dermal injicerbar steril sammensætning Download PDF

Info

Publication number
DK2912074T3
DK2912074T3 DK13820892.1T DK13820892T DK2912074T3 DK 2912074 T3 DK2912074 T3 DK 2912074T3 DK 13820892 T DK13820892 T DK 13820892T DK 2912074 T3 DK2912074 T3 DK 2912074T3
Authority
DK
Denmark
Prior art keywords
injectable sterile
sterile composition
dermal
dermal injectable
composition
Prior art date
Application number
DK13820892.1T
Other languages
English (en)
Other versions
DK2912074T4 (da
Inventor
François Bourdon
Stéphane Meunier
Original Assignee
Teoxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2912074(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane filed Critical Teoxane
Application granted granted Critical
Publication of DK2912074T3 publication Critical patent/DK2912074T3/da
Publication of DK2912074T4 publication Critical patent/DK2912074T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK13820892.1T 2012-10-24 2013-10-24 Dermal injicerbar steril sammensætning DK2912074T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260146A FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable
PCT/IB2013/059607 WO2014064632A1 (en) 2012-10-24 2013-10-24 Dermal injectable sterile composition

Publications (2)

Publication Number Publication Date
DK2912074T3 true DK2912074T3 (da) 2019-07-22
DK2912074T4 DK2912074T4 (da) 2022-03-14

Family

ID=47754646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13820892.1T DK2912074T4 (da) 2012-10-24 2013-10-24 Dermal injicerbar steril sammensætning

Country Status (19)

Country Link
US (2) US9907739B2 (da)
EP (1) EP2912074B2 (da)
JP (1) JP6521862B2 (da)
KR (1) KR102178252B1 (da)
AU (1) AU2013336274B2 (da)
BR (1) BR112015009162B1 (da)
CA (1) CA2888616C (da)
DK (1) DK2912074T4 (da)
ES (1) ES2735017T5 (da)
FR (1) FR2997014B1 (da)
HR (1) HRP20191196T1 (da)
HU (1) HUE044362T2 (da)
PL (1) PL2912074T5 (da)
PT (1) PT2912074T (da)
RS (1) RS59079B1 (da)
RU (1) RU2653729C2 (da)
SI (1) SI2912074T1 (da)
TR (1) TR201911149T4 (da)
WO (1) WO2014064632A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6906885B2 (ja) 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
US11254792B2 (en) 2015-12-29 2022-02-22 Galderma Holding SA Method for deacetylation of biopolymers
US20200054786A1 (en) * 2016-10-13 2020-02-20 Allergan, Inc. Coacervate hyaluronan hydrogels for dermal filler applications
EP3562469A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
WO2018122342A1 (en) * 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
WO2018122344A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
KR20200121828A (ko) * 2018-02-16 2020-10-26 도요보 가부시키가이샤 안티폴루션제 및 피부외용 조성물
WO2019238954A1 (en) 2018-06-15 2019-12-19 Croma-Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
BR112020024654B1 (pt) 2018-06-15 2024-02-27 Croma-Pharma Gmbh Composição de hidrogel estéril, unidade de aplicação para injeção,seus usos, método cosmético, enchimento de tecido mole, e implante ou depósito
KR20210008860A (ko) 2018-06-29 2021-01-25 더 프록터 앤드 갬블 캄파니 이중상 제품
JP7160954B2 (ja) 2018-06-29 2022-10-25 ザ プロクター アンド ギャンブル カンパニー 二相製品
WO2020005788A2 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Dual phase products
WO2020005787A2 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Dual phase products
EP3804769B1 (en) 2018-07-06 2025-05-21 Lg Chem, Ltd. Hyaluronic acid filler having high viscoelasticity and high cohesiveness
EP3804770B1 (en) * 2018-07-10 2023-12-06 Lg Chem, Ltd. Hyaluronic acid filler having high lift capacity and low injection force
WO2020111888A1 (ko) * 2018-11-30 2020-06-04 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물
RS67193B1 (sr) * 2018-12-20 2025-10-31 Lg Chemical Ltd Filer sa odličnim svojstvima filera koji obuhvata hidrogel hijaluronske kiseline
JP1665824S (da) 2019-08-21 2020-08-11
JP2022544693A (ja) * 2019-08-30 2022-10-20 ザ プロクター アンド ギャンブル カンパニー パッケージングされたヘアケア組成物
PL4077402T3 (pl) 2019-12-19 2024-07-29 Croma-Pharma Gmbh Kwas hialuronowy modyfikowany tiolem i hydrożel zawierający usieciowany kwas hialuronowy
US11752074B2 (en) 2020-10-27 2023-09-12 The Procter & Gamble Company Warming conditioner
USD1006632S1 (en) 2020-12-11 2023-12-05 The Procter & Gamble Company Container for hair care products
USD1012718S1 (en) 2020-12-21 2024-01-30 The Procter & Gamble Company Container for hair care product
US20220332902A1 (en) * 2021-04-09 2022-10-20 Colorado School Of Mines Radical crosslinked zwitterionic gels and uses thereof
EP4431551A4 (en) * 2021-11-10 2024-12-25 Imeik Technology Development Co., Ltd. Gel material, preparation method therefor, and use thereof
CN113896915B (zh) * 2021-11-10 2024-02-13 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
CN116173293B (zh) 2021-11-29 2025-05-16 爱美客技术发展股份有限公司 一种复合凝胶、制备方法及应用
AR128245A1 (es) 2022-01-11 2024-04-10 Gpq S R L Nuevos derivados de ácido hialurónico como rellenos innovadores
WO2023221082A1 (zh) * 2022-05-20 2023-11-23 爱美客技术发展股份有限公司 一种接枝聚合物材料及其制备方法与应用
WO2024040480A1 (zh) * 2022-08-24 2024-02-29 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法
CN119286070B (zh) * 2024-10-30 2026-01-13 陕西科技大学 一种基于铜离子交联改性的透明质酸水凝胶及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) † 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) * 2003-02-18 2004-08-19 Trubetskoy Vladimir S. Delivery of siRNA to cells using polyampholytes
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
NO20044818D0 (no) 2004-11-05 2004-11-05 Bioforsk As Spermin i kosmetiske preparater
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
CN101107270B (zh) 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
FR2908415B1 (fr) † 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
WO2010049562A1 (es) 2008-10-28 2010-05-06 Universidade De Santiago De Compostela Sistemas nanoparticulares elaborados a base de polímeros aniónicos.
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
ES2368307B1 (es) * 2010-04-28 2012-10-17 Universidade De Santiago De Compostela Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
CA2805008C (en) * 2010-07-12 2015-05-12 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue augmentation comprising a hydrogel of hyaluronic acid cross-linked with alkylene diamine

Also Published As

Publication number Publication date
CA2888616A1 (en) 2014-05-01
CA2888616C (en) 2020-09-15
RS59079B1 (sr) 2019-09-30
JP6521862B2 (ja) 2019-05-29
US9907739B2 (en) 2018-03-06
EP2912074B2 (en) 2021-12-22
EP2912074A1 (en) 2015-09-02
ES2735017T5 (es) 2022-04-28
ES2735017T3 (es) 2019-12-13
DK2912074T4 (da) 2022-03-14
SI2912074T1 (sl) 2019-08-30
KR102178252B1 (ko) 2020-11-13
BR112015009162A2 (pt) 2017-10-03
HUE044362T2 (hu) 2019-10-28
FR2997014A1 (fr) 2014-04-25
EP2912074B1 (en) 2019-05-01
US20150272851A1 (en) 2015-10-01
JP2016507592A (ja) 2016-03-10
WO2014064632A1 (en) 2014-05-01
PT2912074T (pt) 2019-07-19
BR112015009162B1 (pt) 2021-10-13
KR20150079786A (ko) 2015-07-08
PL2912074T3 (pl) 2019-09-30
HRP20191196T1 (hr) 2019-10-18
AU2013336274B2 (en) 2017-08-24
US20180140530A1 (en) 2018-05-24
RU2015118969A (ru) 2016-12-20
AU2013336274A1 (en) 2015-05-07
FR2997014B1 (fr) 2015-03-20
PL2912074T5 (pl) 2022-04-04
RU2653729C2 (ru) 2018-05-14
US10307362B2 (en) 2019-06-04
TR201911149T4 (tr) 2019-08-21

Similar Documents

Publication Publication Date Title
DK2912074T3 (da) Dermal injicerbar steril sammensætning
DK3777834T3 (da) Sprøjte
DK3685826T3 (da) Sprøjte
BR112014031223A2 (pt) composições de tratamento de polímero
EP2832391A4 (en) SYRINGE
PL2825212T3 (pl) Ulepszony sposób sterylizacji
DK2868318T3 (da) Injicerbar formulering
EP2913076A4 (en) SYRINGE
PT2825039T (pt) Formulação de ibuprofeno injetável
EP2889016A4 (en) DENTAL SYRINGE
EP2931176A4 (en) Medical sling
EP2851085A4 (en) STERILIZED COMPOSITION
FR2973990B1 (fr) Implant dermique
UA24520S (uk) Шприц медичний
UA24471S (uk) Шприц медичний
UA24469S (uk) Шприц медичний
EP2885023A4 (en) SYRINGE